Cost Effectiveness Analysis of The Use of Daclatasvir for the Treatment of Hepatitis C Virus (Hcv) Genotypes 3 in Cirrhotic Patients Within the Italian National Health Service
2015 ◽
Vol 2
(2)
◽
pp. GRHTA.5000201
◽
2018 ◽
Vol 34
(2)
◽
pp. 534-552
2012 ◽
Vol 19
(5)
◽
pp. 459-465
◽
Keyword(s):
2004 ◽
Vol 24
(5)
◽
pp. 309-316
◽